Liara Rizzi, PhD, MSc

[Mayana Zatz @Mayanazatz]

Porque estamos pesquisando super Centenarios https://t.co/RAlTz30hOf

[Lea T. Grinberg, M.D, Ph.D @grinberg_t]

https://t.co/9f3xPEHSpF New review in @alzdemjournals: Objective data show tau changes arise before amyloid in #Alzheimer. An amyloid-only model is oversimplistic:integrated PET, fluid, genetic & transcriptomic data show intertwined roles of tau, inflammation & amyloid @ISTAART

[Lea T. Grinberg, M.D, Ph.D @grinberg_t]

🇧🇷🧠 A força da ciência brasileira em peso no #AAIC2025!
Mais de 100 clínicos e pesquisadores reunidos mostrando o impacto do Brasil na luta contra as #demências.
Orgulho, conhecimento e colaboração transbordando! 💪✨
@ISTAART @CaramelliPaulo @zimmerlab1

[Mayo Clinic @MayoClinic]

For the 36th consecutive year since U.S. News & World Report launched its "Best Hospitals" rankings, Mayo Clinic again ranks at the top of the 2025–2026 list.

Read more: https://t.co/mVhFe0Np7A

[Alzheimer's Association @alzassociation]

It has been another fantastic day of discovery at #AAIC25. For those in Toronto, look up to the night sky tonight to catch buildings shining in purple in honor of the conference and Alzheimer’s awareness.💜

[ISTAART @ISTAART]

We had so much fun tonight at the AAIC25 Welcome Reception! 💃🎶
The energy was incredible, and it’s just the beginning. Stay tuned for more exciting receptions and events throughout the week—we can’t wait! #ISTAART #AAIC25

[Dr. Patricia Schmidt 🧠 @creatorschmidt]

I’m a scientist with a doctorate in Psychology & a focus on Neuroscience.

Here are 12 controversial truths about mental & brain health you won’t like—but need to hear:

[CNN Brasil @CNNBrasil]

Um estudo feito na Universidade Estadual de Campinas (Unicamp) comprovou outro efeito importante da musculação: proteger o cérebro de idosos contra demências. Os resultados foram divulgados na revista GeroScience. #CNNPrimeTime

[AD/PD - Advances in Science & Therapy @adpdnet]

🧠 This Brain Awareness Week, we shine a light on the urgent need to understand and combat #Alzheimers, #Parkinsons, and related #neurodegenerative diseases. Every breakthrough in research brings us closer to better treatments, prevention strategies, and ultimately, a cure.

At #ADPD2025, leading scientists, clinicians, and researchers will gather to share the latest discoveries shaping the future of #brainhealth.

Join us next month in Vienna and be part of the conversation 👉 https://t.co/Lg40WuVSCj

#BrainAwarenessWeek #dementia #endalz #neuroscience #neuroscientist #researcher

[World Dementia Council @WorldDementia]

Ahead of Friday’s virtual roundtable Latin America and the Caribbean: Awareness and Understanding, revisit our blog by series co-chairs @NeuroAllegri and @CaramelliPaulo and learn more about the programme: https://t.co/s5H4oFnaDk

[Suzanne E Schindler @SuzanneESchind1]

There is a misconception that only amyloid-targeting treatments have been studied in Alzheimer's disease. The reality is that clinical trials have evaluated many, many treatments unrelated to amyloid over the past few decades. Please see the chart below from 2016, which shows the large number of non-amyloid-targeting treatments that were in trials ~9 years ago. With rare exceptions (acetylcholinesterase inhibitors, memantine), the non-amyloid-targeting treatments did not work.

Amyloid-targeting treatments are the only disease-modifying treatments that have demonstrated any clinical efficacy in slowing Alzheimer's disease so far in rigorous phase 3 clinical trials. Researchers/clinicians often talk about anti-amyloid treatments not because other types of treatments haven’t been considered or evaluated, but because some anti-amyloid treatments have demonstrated efficacy and are clinically available.

We do need even more effective treatments and researchers are continuing to evaluate many types of treatments in numerous trials. In 2024, there were 164 clinical trials assessing 127 drugs with a wide array of targets including neurotransmitter receptors, inflammation, and synaptic plasticity: (https://t.co/GpZMOC7fx6).

Researchers have been exploring a wide variety of treatments for a long time and will keep working to find effective treatments for Alzheimer's disease. #ENDALZ

[Paulo Caramelli @CaramelliPaulo]

Alzheimer's disease as a clinical-biological construct - IWG 2024 Recommendations.

[Prof. Melissa E. Murray 📸🔬 @DrNeuroChic]

What a happy way to celebrate a Friday, @dennis_w_d and I welcomed the @GrinbergLabUCSF to Mayo for @CityofJax visit. Feels like a dream come true after such a long lasting friendship and collaborative history with @grinberg_t

@gowoon_son @flpsw @LiaraR_
@AbhijitSatpati @TiaLamore

[Lea T. Grinberg, M.D, Ph.D @grinberg_t]

Important study highlights how addressing environmental risk factors in LMICs could reduce the burden and costs of dementia @GBHI_Fellows

[Ian Kremer @LEAD_Coalition]

10 Ways to fuel your #wellbeing tank.

(image: @BelievePHQ) #wellness #mentalhealth

[Ian Kremer @LEAD_Coalition]

The 7 Eating Habits That May Actually Work to Fight #Dementia Risk, Says Science https://t.co/wVDjusXULF

#Alzheimers #food #diet #nutrition

[Alzforum @alzforum]

At AAIC 2024, phospho-tau assays look ready for primary and secondary care. @lunduniversity @wustl @BannerAlzheimer https://t.co/AMJNPgZpVX

[Ian Kremer @LEAD_Coalition]

Understanding the many possible paths to #dementia https://t.co/4oxwV1u9nS

#Alzheimers #stroke

[Lea T. Grinberg, M.D, Ph.D @grinberg_t]

From Suvarna Alladi's plenary at #AAIC2024: Bilingualism delays dementia onset by 4 years. A wake-up call to start second language education early in the USA. Proud to have Suvarna as a mentor for @GBHI_Fellows @claire_e_sexton @victorvalcour @alzassociation

[RikOssenkoppele @RikOssenkoppele]

Great to learn from @NeuroAllegri about their impressive body research but also all the challenges that needs/needed to be overcome in low- and middle-income countries. #AAIC24